Texas Treasury Safekeeping Trust Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,154
Closed -$535K 7
2026
Q1
$535K Buy
+6,154
New +$598K 0.09% 5
2025
Q1
Sell
-4,230
Closed -$237K 7
2024
Q4
$237K Hold
4,230
0.01% 9
2024
Q3
$222K Hold
4,230
0.01% 9
2024
Q2
$174K Hold
4,230
0.01% 9
2024
Q1
$183K Hold
4,230
0.01% 9
2023
Q4
$194K Hold
4,230
0.02% 9
2023
Q3
$97K Hold
4,230
0.02% 8
2023
Q2
$70K Hold
4,230
0.02% 8
2023
Q1
$75K Buy
+4,230
New +$106K 0.02% 8

Other funds holding RYTM

Texas Treasury Safekeeping Trust Company's RYTM Position: Q2 2026 in Review

Texas Treasury Safekeeping Trust Company sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 6,154 shares — an estimated $535K sold.

Texas Treasury Safekeeping Trust Company first reported a position in RYTM in Q1 2023 and held it in 9 quarters. The position peaked at $535K in Q1 2026. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Texas Treasury Safekeeping Trust Company reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Texas Treasury Safekeeping Trust Company sold 6,154 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $535K.
  • Texas Treasury Safekeeping Trust Company first reported a position in Rhythm Pharmaceuticals in Q1 2023 and held it in 9 quarters.
  • Texas Treasury Safekeeping Trust Company's Rhythm Pharmaceuticals position peaked at $535K in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Texas Treasury Safekeeping Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.